EUVIMEDEUVIMED entdecken
Open Access

Region-specific neuroadaptations of CRF1 and CRF2 expression following heroin exposure in female rats

Piper Schneider, Danielle Goldbaum, Ansh Agarwal, Ashton Taylor, Peyton Sundberg, Eliot L Gardner, Robert Ranaldi, Zhi-Bing You, Ewa Galaj

Pharmacology Biochemistry and Behavior · 2025

DOI: 10.1016/j.pbb.2024.173931 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2025. Verfasst von Piper Schneider und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychological and Brain Sciences, Colgate University, Hamilton, NY, USA. Hauptthemen laut MEDLINE: Receptors, Corticotropin-Releasing Hormone, Heroin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While stress increases vulnerability to development of addiction, the recruitment of corticotropin releasing factor (CRF) with excessive drug use heightens the risk of stress-induced relapse. CRF signaling is transmitted via CRF1 and CRF2 receptors, but the roles of these receptors in heroin self-administration and related neuroadaptations of the CRF system within mesolimbic brain loci are not well understood. In this study, we first investigated the causal role of CRF1 and CRF2 receptors in heroin self-administration. Intracerebroventricular (ICV) microinjections of antalarmin (a CRF1 antagonist) or astressin-2B (a CRF2 antagonist) caused brief, dose-dependent reductions in heroin self-administration in female rats, suggesting that these receptors play a critical role in heroin-motivated behaviors. We then used western blotting to examine neuroadaptive changes to CRF1 and CRF2 receptor expression in key forebrain and midbrain regions associated with opioid addiction. Female Long Evans rats treated with escalating doses of heroin for 16 days demonstrated significantly higher naloxone-precipitated withdrawal symptoms than saline-treated rats. Heroin-treated rats showed a significant decrease in CRF1 receptor protein expression in the ventral tegmental area (VTA) and an increase in the nucleus accumbens (NAc) but no changes in the prefrontal cortex (PFC), insula, dorsal striatum (dSTR), dorsal hippocampus (dHippo), anterior hypothalamus (HYPTH), amygdala, or substantia nigra (SN) as compared to saline-treated rats. After chronic heroin exposure, CRF2 receptor expression was significantly downregulated in the dHippo, VTA and HYPTH but not in the other brain regions we investigated. The results of this study suggest that: (1) CRF1 and CRF2 receptors play an important role in self-administration and (2) heroin exposure may lead to region-specific neuroadaptation of CRF1 and CRF2 receptors. Such neuroadaptations might in part contribute to the continuation of drug use and stress-induced relapse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Corticotropin-Releasing HormoneHeroinAnimalsFemaleCRF Receptor, Type 1RatsRats, Long-EvansSelf AdministrationPyrimidinesCorticotropin-Releasing HormonePeptide FragmentsPyrrolesPeptides, Cyclic

Stichwörter der Autor:innen

CRF1CRF2Drug self-administrationHeroinNaloxoneNeuroadaptationsNucleus accumbensOpioidVentral tegmental areaWithdrawal symptoms

Substanzen

Receptors, Corticotropin-Releasing HormoneCRF Receptor, Type 1CRF receptor type 2HeroinantalarminPyrimidinesCorticotropin-Releasing HormonePeptide FragmentsPyrrolesastressin-2B

Autor:innen und Institutionen

  • Department of Psychological and Brain Sciences, Colgate University, Hamilton, NY, USA.
  • Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.
  • The Graduate Center of the City University of New York, New York, NY, USA; Department of Psychology, Queens College of the City University of New York, Flushing, NY, USA.
  • Department of Psychological and Brain Sciences, Colgate University, Hamilton, NY, USA. Electronic address: egalaj@colgate.edu.

Förderung

  • NIDA NIH HHS
  • NIGMS NIH HHS
  • National Institute of General Medical Sciences
  • National Institute on Drug Abuse
  • National Institutes of Health
  • Intramural Research Program

Zitieren

APA

Schneider, P., Goldbaum, D., Agarwal, A., Taylor, A., Sundberg, P., Gardner, E. L., Ranaldi, R., You, Z. B., & Galaj, E. (2025). Region-specific neuroadaptations of CRF1 and CRF2 expression following heroin exposure in female rats. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2024.173931

Vancouver

Schneider P, Goldbaum D, Agarwal A, Taylor A, Sundberg P, Gardner EL, et al. Region-specific neuroadaptations of CRF1 and CRF2 expression following heroin exposure in female rats. Pharmacology Biochemistry and Behavior. 2025. doi:10.1016/j.pbb.2024.173931

BibTeX
@article{Schneider2025,
  author = {Schneider, Piper and Goldbaum, Danielle and Agarwal, Ansh and Taylor, Ashton and Sundberg, Peyton and Gardner, Eliot L and Ranaldi, Robert and You, Zhi-Bing and Galaj, Ewa},
  title = {Region-specific neuroadaptations of CRF1 and CRF2 expression following heroin exposure in female rats},
  journal = {Pharmacology Biochemistry and Behavior},
  year = {2025},
  doi = {10.1016/j.pbb.2024.173931}
}
Kostenlos starten →